Nanjing, China

Jihui Ping

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jihui Ping: Innovator in Influenza Vaccine Development

Introduction

Jihui Ping is a notable inventor based in Nanjing, China. He has made significant contributions to the field of vaccine development, particularly in relation to influenza viruses. With a total of 2 patents, his work focuses on enhancing the replication of influenza viruses for vaccine purposes.

Latest Patents

Jihui Ping's latest patents include innovative methods for influenza B virus replication aimed at vaccine development. The first patent provides a composition useful for preparing high titer influenza B viruses without the need for a helper virus. This composition includes internal genes from a safe influenza B virus vaccine strain, which enhances growth in cell cultures, such as MDCK cells, or in eggs. The second patent describes an isolated recombinant influenza virus that has enhanced replication capabilities. This virus features specific modifications in its viral segments, allowing for improved performance compared to traditional influenza viruses.

Career Highlights

Jihui Ping is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research in virology and vaccine development. His work is critical in the ongoing efforts to combat influenza and improve public health outcomes.

Collaborations

Jihui Ping has collaborated with esteemed colleagues in the field, including Yoshihiro Kawaoka and Gabriele Neumann. These partnerships have further enriched his research and contributed to the advancement of vaccine technologies.

Conclusion

Jihui Ping's innovative work in influenza vaccine development showcases his commitment to enhancing public health through scientific research. His patents reflect a deep understanding of virology and a dedication to improving vaccine efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…